![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 2008, American Society for Microbiology Downregulation of Vertebrate Tel (ETV6) and Drosophila Yan Is Facilitated by an Evolutionarily Conserved Mechanism of F-Box-Mediated Ubiquitination §Leiden University Medical Center (LUMC), Signaling and Transcription Laboratory, Department of Molecular Cell Biology, 2300 RC Leiden, The Netherlands,1 Laboratory of Gastroenterology and Hepatology, Erasmus University Medical Center, 2040 CA Rotterdam, The Netherlands2 *Corresponding author. Mailing address: Leiden University Medical Center (LUMC), Department of Molecular Cell Biology, 2300 RC Leiden, The Netherlands. Phone: 31 71 526 9223. Fax: 31 71 526 8270. E-mail: d.baker/at/lumc.nl †These authors contributed equally to this work. Received October 24, 2007; Revised February 6, 2008; Accepted April 11, 2008. Abstract The vertebrate Ets transcriptional repressor Tel (ETV6) and its invertebrate orthologue, Yan, are both indispensable for development, and they orchestrate cell growth and differentiation by binding to DNA, thus inhibiting gene expression. To trigger cell differentiation, these barriers to transcriptional activation must be relieved, and it is established that posttranslational modifications, such as phosphorylation and sumoylation, can specifically impair the repressive functions of Tel and Yan and are crucial for modulating their transcriptional activity. To date, however, relatively little is known about the control of Tel and Yan protein degradation. In recent years, there has been a concentrated effort to assign functions to the large number of F-box proteins encoded by both vertebrate and invertebrate genomes. Here, we report the identification and characterization of a previously unreported, evolutionarily conserved F-box protein named Fbl6. We isolated both human and Drosophila melanogaster fbl6 cDNA and show that the encoded Fbl6 protein binds to both Tel and Yan via their SAM domains. We demonstrate that both Tel and Yan are ubiquitinated, a process which is stimulated by Fbl6 and leads to proteasomal degradation. We recently established that the sumoylation of Tel on lysine 11 negatively regulates its repressive function and that the sumoylation of Tel monomers, but not that of Tel oligomers, may sensitize Tel for proteasomal degradation. Here, we found that Fbl6 regulates Tel/Yan protein stability and allows appropriate spatiotemporal control of gene expression by these repressors. Cell fate is determined by programs of gene expression, which are strictly regulated spatiotemporally by a complex network of interacting molecular mechanisms that control the balance between transcription, translation, and degradation. The Drosophila melanogaster transcription factor Yan and its vertebrate orthologue, Tel (ETV6), are well placed to interrogate these processes. An abundance of molecular and genetic evidence shows that these unique Ets transcription factor repressors are indispensable for normal cell differentiation (15, 19, 22, 27, 35, 36, 45, 46). Importantly, the disruption of normal Tel function leads to neoplasia (10, 11). A finely controlled interplay between posttranscriptional and posttranslational modifications regulates their functions (42). In the case of Tel, the observed heterogeneity of Tel proteins in cells (37, 29, 43) can be accounted for by at least two posttranscriptional mechanisms—the use of an alternative initiation codon (37, 29) and alternative splicing (38; M. G. Roukens and D. A. Baker, unpublished data). Together, these processes can produce Tel isoforms that differentially control Tel function. Yan, on the other hand, appears to be regulated posttranscriptionally by a microRNA, miR7, that might act in a tissue-specific fashion and that limits Yan protein translation by binding to the 3′ untranslated region of yan mRNA (21). Posttranslationally, phosphorylation and sumoylation play pivotal roles in modulating the activities of Tel and Yan, particularly by impairing the repression of transcription by these factors. Specifically, phosphorylation of Yan is a trigger for its downregulation (2, 33, 35, 40, 41), and sumoylation of Tel is PIAS dependent (37) and inhibits the repression of gene expression (5, 37, 49). To date, however, relatively little is known about the control of Tel/Yan protein degradation. There are vital mechanisms of protein degradation for controlling the timing of the action of proteins and, ultimately, the timing of cellular processes in general. One such crucial mechanism of degradation is mediated by the process of ubiquitination, which impinges on virtually all known eukaryotic cellular processes (13). Ubiquitin is a 76-amino-acid polypeptide that can be covalently bonded to target proteins in a number of ways (28). Monoubiquitination has been shown to play an essential role in endocytosis (16) and in the subcellular targeting of proteins (20). Polyubiquitination, in contrast, is almost exclusively associated with protein degradation and turnover, either via the proteasome or through endocytosis and lysosomal sorting (47). Mechanistically, ubiquitination is well defined and involves the concerted action of at least three different catalytic components, namely the E1 (ubiquitin-activating), E2 (ubiquitin-conjugating), and E3 (ubiquitin ligase) enzymes (48). A crucial aspect of ubiquitination-driven degradation is how substrate specificity is achieved. One way is through the recruitment of F-box proteins. F-box proteins are characterized by the presence of an N-terminal F-box domain that is approximately 50 amino acids long (1), and they are broadly classified into three families: the FBW family, which contains WD repeats; the FBL family, which contains leucine-rich repeats; and the FBX family, which consists of F-box proteins with other protein interaction domains. These domains are usually located in the C terminus of the protein, and they associate with substrates and link them to the ubiquitinating machinery via the F-box domain (4, 14). We have performed yeast two-hybrid screens to identify proteins that associate with both Tel and Yan, and by this means, we have uncovered an F-box protein named Fbl6. Our biochemical and genetic analyses of human and Drosophila tissue culture cells, as well as of Drosophila embryos, suggest that F-box-mediated ubiquitination of Tel and Yan promotes their downregulation. MATERIALS AND METHODS Cell-based ubiquitination assays. Cells were transfected with the appropriate plasmids and then incubated for 6 h with or without the proteasome inhibitor MG132 24 to 36 h posttransfection. His-ubiquitin pulldowns were performed with 50 μl of Ni-nitrilotriacetic acid beads (Qiagen) for 3 h at room temperature in 6 ml of 6 M guanidinium-HCl, 0.1 M Na2HPO4, 0.1 M NaH2PO4, 0.01 M Tris-HCl (pH 8.0), 20 mM imidazole, and 10 mM β-mercaptoethanol (buffer A). The beads were successively washed twice with 1 ml of each of the following buffers: (i) buffer A plus 0.2% Triton X-100; (ii) 8 M urea, 0.1 M Na2HPO4, 0.1 M NaH2PO4, 0.01 M Tris-HCl (pH 8.0), 20 mM imidazole, 10 mM β-mercaptoethanol, and 0.2% Triton X-100 (buffer B); and (iii) 8 M urea, 0.1 M Na2HPO4, 0.1 M NaH2PO4, 0.01 M Tris-HCl (pH 6.3), 20 mM imidazole, 10 mM β-mercaptoethanol, and 0.2% Triton X-100 (buffer C). Ubiquitinated proteins were eluted in 60 μl of urea sample buffer, which consisted of 37.5% buffer C, 39.3% 3× Laemmli buffer, 20 mM imidazole, and 3.2% β-mercaptoethanol. The samples were boiled and analyzed by Western blotting. Immunofluorescence. Cells were grown on glass coverslips and transfected using Fugene 6 (Roche). Cells were fixed after 24 h with 4% paraformaldehyde for 15 min at room temperature (all of the following steps were done at room temperature) and permeabilized in 0.2% Triton X-100-phosphate-buffered saline for 5 min. Cells were washed with phosphate-buffered saline and blocked with 5% goat serum for 1 h, incubated with primary antibodies for 1 h, washed, and incubated with secondary antibodies for 30 min. Following extensive washing, the cells were mounted and immunostaining was visualized with a Leica DM5500 B microscope. Cell culture, biochemistry, and molecular biology. A schematic representation of all of the constructs used in this study can be found in Fig. S3 in the supplemental material and also in the relevant figures. Mammalian cell lines were cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum and antibiotics. Drosophila Schneider cells were cultured at 25°C in Schneider cell medium (Sigma) supplemented with 10% fetal bovine serum. Mammalian cells were transfected with Fugene 6 (Roche) and insect cells with Effectene reagent (Qiagen), according to the manufacturers' protocol. In general, 1 μg of each construct was transfected into cells seeded at 40 to 60% confluence in 6-cm tissue culture dishes, and cells were lysed 24 to 48 h posttransfection. TelHA,TelFlag, YanHA, and YanFlag constructs were fused in frame with either a hemagglutinin (HA) or a Flag epitope tag and cloned into either the pCS2 expression vector for expression in mammalian cells or the pMT vector (Invitrogen) for expression in insect cells. Glutathione S-transferase (GST)-Tel was cloned in frame with GST in the pGEX-2TK vector. Mutants were generated by PCR. For immunoprecipitations, cells were lysed in 1 ml of either radioimmunoprecipitation assay-sodium dodecyl sulfate buffer (1 mM EDTA, 50 mM Tris [pH 8.0], 150 mM NaCl, 10% glycerol, 1% Triton X-100) or protein lysis buffer (50 mM Tris [pH 7.5], 1% NP-40, 0.1% sodium dodecyl sulfate, 0.5% Na deoxycholate, 150 mM NaCl) with protease inhibitors (phenylmethylsulfonyl fluoride, trypsin, pepstatin A, leucine, aprotinin) and NaF. Cell lysates were syringed and centrifuged. Immunoprecipitations were carried out with 0.75 μl of either anti-HA polyclonal antibody (Abcam) or anti-V5 monoclonal antibody (Invitrogen). Lysates were preincubated with the antibody for 1 h, after which suitable beads, protein A-Sepharose 4 fast flow (Amersham Pharmacia Biotech) for HA immunoprecipitations or protein G-Sepharose (Sigma-Aldrich) for V5 immunoprecipitations, were added for a further 2 h of incubation. Associated proteins were analyzed by Western blotting. For pulldown assays, Fbl6 proteins were labeled with [35S]methionine by using the TNT coupled reticulocyte in vitro translation system (Promega) and then incubated with GST-Tel fusions that were immobilized on glutathione-Sepharose beads as previously described (2). Production and infection with shRNA-expressing lentiviruses. Short hairpin RNA (shRNA) lentiviral constructs for the knockdown of fbl6 were cloned by insertion of the following oligonucleotides into the BglII/HindIII sites of the pSuper vector: fbl6i#1 (5′-GATCGCAAGTTGTGGCTGACCTATTCAAGAGATAGGTCAGCCACAACTTGCTTTTT-3′ and 5′ AGCTAAAAAGCAAGTTGTGGCTGACCTATCTCTTGAATAGGTCAGCCACAACTTGC-3′) and fbl6i#2 (5′-GATCGCATCAACCGTAATAGCATTTCAAGAGAATGCTATTACGGTTGATGCTTTTT-3′ and 5′-AGCTAAAAAGCATCAACCGTAATAGCATTCTCTTGAAATGCTATTACGGTTGATGC-3′). The pSuper constructs were subsequently digested with PstI and XhoI, and the fragment was placed in the lentiviral PLV-cytomegalovirus-green fluorescent protein vector. shRNA lentiviral constructs for the knockdown of S-phase kinase-associated protein 1 (Skp1) were obtained from the Mission shRNA library (Sigma-Aldrich clones TRCN 006 496 and TRCN 011 029). Recombinant lentiviruses were produced by the transfection of 293T cells. Transduction of U2OS cells was performed at a multiplicity of infection of 1, with the addition of Polybrene in a final concentration of 8 μg/ml. One day postinfection, the medium was replaced with fresh medium (supplemented with puromycin for the skp1 lines), and cells were lysed after 48 h. In vivo 35S labeling. Cells were washed free of medium and seeded into 6-cm tissue culture dishes (Gibco) in methionine- and serum-free Dulbecco modified Eagle medium (Gibco). Cells were routinely incubated for 3 h, and then the medium was supplemented with 50 μCi 35S-labeled methionine for an additional 3 h of labeling. Labeled HA epitope-tagged Tel proteins were immunoprecipitated from the cell lysates as described above. Baculovirus production and expression in cells. Recombinant baculoviruses for expression in SF9 cells were generated using the Bac-to-Bac baculovirus expression system (Invitrogen) according to the manufacturer's manual. For the ubiquitination assay, SF9 cells were seeded in Grace's medium (Invitrogen) at 40 to 60% confluence in 6-cm culture dishes and infected with recombinant viruses. Analysis of gene expression by quantitative PCR. All methods were performed essentially as described previously (37). The following primer sets were deployed for real-time PCR analysis: Telq15 (CCCTGCGCCACTACTACAA) and Telq13 (TGATTTCATCTGGGGTTTTCA), Telq25 (CTTTCGCTATCGATCTCCTCA) and Telq23 (AGGGTGGAAGAATGGTGAAA), hFbl615 (ATGCCCAATCGGTTTTCA) and hFbl613 (AGGACAGCACTCACCTACCAG), hFbl625 (GGATCTTCGTGGCTGTGC) and hFbl623 (CATACAGGCCCAGATGAAGC), hSKP1A15 (GGAGATTCGCAAGACCTTCA) and hSKP1A13 (CACTGGTTCTCTTTGCGTACC), and Gapdh5 (TGCCATGTAGACCCCTTGAAG) and Gapdh3 (ATGGTACATGACAAGGTGCGG). Drosophila genetics and embryo analysis. P{GawB}NP0326, Df(2R)stan1, and Df(2R)Exel6060 fly stocks were obtained from the Bloomington Stock Center. Stocks were maintained using balancers expressing the green fluorescent protein. Reverted flies were generated by transposase-mediated precise excision of the P element in P{GawB}NP0326 flies. Precise excision was confirmed by the sequencing of fly genomic DNA. Stocks were maintained under standard conditions, and crosses were performed by following standard procedures. For expression analyses, embryos were carefully staged, and total RNA was prepared using the SV total RNA isolation kit in accordance with the manufacturer's protocol (Promega). Following cDNA synthesis using a TaqMan kit (Roche), expression levels of relevant transcripts were determined by PCR using the following primer sets: the fbl6 sense primer (AGGTCCTGCGTGTGACAAACTCTC) and the fbl6 antisense primer (GAGGCAATGAGTTGGATGTGAAC); the argos sense primer (GGATTTTCTGTTTGATCAGTTC) and the argos antisense primer (ATTATTGGATATTTCATTCACT); the CG18335 sense primer, (ATAACGCCGGAACCGCACTTGGTG) and the CG18335 antisense primer (GTAAACGGAGTCCACCAAACCCTC); the CG13220 sense primer (ACCTGACGAACGTGTTCCTCATCTC) and the CG13220 antisense primer (GGTTCGAATACCTCAGTCCTATATC); the tubulin sense primer (CGTTCACATCCAAGCTGGTCAG) and the tubulin antisense primer (GGGTGCGGAAGCAGATATCG). Yeast two-hybrid assay and cDNA cloning. Full-length yan or tel cDNA was cloned into pAS2-1 (Clontech) in frame with the GAL4 DNA binding domain. Independent transformants (approximately 5 × 105) from a GAL4 activation domain Drosophila embryo library (for Yan) or a human bone marrow library (for Tel) were screened in Saccharomyces cerevisiae Hf7c cells according to the manufacturer's protocol (Clontech). We confirmed the specificities of interactions between Yan and Drosophila Fbl6 and between Tel and human Fbl6 by transforming yeast with the cDNA of fbl6, in either the presence or the absence of the yan bait (for Drosophila fbl6), the tel bait (for human fbl6), or an unrelated bait. Full-length cDNAs of the human fbl6 gene and of the Drosophila fbl6 gene were isolated by reverse transcriptase (RT)-PCR using total RNA derived from either insect Schneider cells (for Drosophila fbl6) or U2OS human osteosarcoma cells (for human fbl6). Antibodies/drugs. The following antibodies (and dilutions, if applicable) were used: anti-V5 antibody (Invitrogen); anti-Flag mouse M2 monoclonal antibody (Sigma-Aldrich); anti-HA.11 mouse monoclonal antibody (Covance); anti-GST rabbit antibody (My Probe), 1:5,000; anti-HA rabbit polyclonal antibody (Abcam), 1:1,000; human anti-Tel rabbit polyclonal antibody, 1:1,000; anti-Yan monoclonal antibody, 1:500; Drosophila anti-SKPA rabbit polyclonal antibody, 1:1,000; and anti-His polyclonal antibody, 1:1,000. For MG132, experiment cells were incubated with 3 μM MG132 (Calbiochem) for 6 h prior to lysis. RESULTS Fbl6, a conserved F-box-containing protein, associates biochemically with both human Tel and Drosophila Yan. To uncover evolutionarily conserved pathways that might regulate Yan/Tel function, we performed yeast two-hybrid screens using either Drosophila Yan or its human orthologue, Tel, as bait to identify common interacting proteins. Proteins that were recovered from both of the independent screens are highlighted in Fig. S1 in the supplemental material. Since posttranslational modifications are essential modulators of protein function, we centered our subsequent analyses on Fbl6, a putative mediator of protein degradation. Figure Figure1A1A
The Tel SAM domain and Fbl6 LRDs are required for their binding. We engineered a V5 epitope-tagged version of wild-type human Fbl6 and confirmed the biochemical interaction between Tel and Fbl6 in tissue culture cells (Fig. 1B and C
Tel is ubiquitinated. It is firmly established that F-box-containing proteins couple their substrates to the conserved ubiquitinating machinery that targets the protein for proteasome-dependent degradation (14, 18, 48). Thus, we investigated whether Tel is ubiquitinated and whether the ubiquitination of Tel might be regulated by Fbl6. Figure Figure2A2A Fbl6 stimulates Tel downregulation and ubiquitination. We next explored the role of Fbl6 in Tel ubiquitination. Several lines of evidence support a role for Fbl6 in promoting Tel downregulation and ubiquitination. First, deletion of the SAM domain, which is essential for Fbl6 binding to Tel (Fig. (Fig.1B),1B Tel monomers are efficiently ubiquitinated in cells. Numerous studies have established that the SAM domain is essential for the monomers of Tel to form homotypic oligomers (17, 33, 37). Moreover, we showed earlier that the SAM domain is also indispensable both for the binding of Fbl6 and for Tel ubiquitination (Fig. (Fig.1B1B Fbl6 associates with Tel2 and stimulates its ubiquitination. The SAM domain defines a subfamily of Ets transcription factors, including Tel, Tel2, Ets1, and Ets2 from vertebrates as well as Yan and Pointed P2 from Drosophila (23, 34). Since Fbl6 associates with Tel via its SAM domain, we tested whether Fbl6 also interacts with other SAM domain-containing Ets family members. Figure Figure3F3F Drosophila Fbl6 interacts with the Tel orthologue, Yan. Having established a biochemical and functional interaction between human Tel and Fbl6, we next explored whether this mechanism might be evolutionarily conserved. To that end, we isolated a full-length Drosophila fbl6 (also referred to as CG13213) cDNA from insect Schneider cells. Figure 4A and B Fbl6 promotes Yan downregulation and ubiquitination. Next, we determined whether Fbl6 influences Yan protein stability. To that end, we established a number of stable Schneider S2 cell lines and monitored their endogenous Yan protein levels. We and others have established that in Drosophila, a protein named Mae (modulator of the activity of Ets) orchestrates Yan derepression by binding to Yan, thereby disrupting Yan self-association and binding to DNA and sensitizing it to downregulation that is dependent on mitogen-activated protein kinase (2, 33, 40, 41). Figure Figure4C4C Fbl6 regulates Yan protein levels in vivo. In order to investigate the in vivo role of Fbl6, we monitored Yan protein levels in Drosophila embryos that are lacking expression of fbl6. To that end, we analyzed the enhancer trap line, P{GawB}NP0326, which is viable as a homozygote. Figure Figure5A5A Overall, our work suggests that an evolutionarily conserved F-box-protein-dependent degradation pathway participates in the regulation of the activity of both vertebrate Tel and its invertebrate orthologue, Yan. Presumably, this serves to further refine spatiotemporal control of gene expression by these transcriptional repressors. DISCUSSION The ancestral Ets repressor Yan and its vertebrate orthologue, Tel (ETV6), play pivotal roles in the control of cell differentiation (15, 19, 22, 27, 35, 36, 45, 46). Because these factors directly and negatively regulate gene expression (19, 22, 27, 35), deciphering the mechanisms that regulate their activity is crucial for understanding the spatiotemporal control of cell differentiation. We recently found that sumoylation of an N-terminal lysine residue encoded by Tel (TelK11) serves to inhibit repression of gene expression by Tel (37). We have further explored Tel/Yan posttranslational regulation, and here we report that both Tel and Yan protein downregulation is promoted by an evolutionarily conserved F-box-protein-dependent mechanism. Specifically, we found that both Tel and Yan can be ubiquitinated and that ubiquitination is facilitated by Fbl6, which sensitizes these proteins for degradation. It is, of course, possible that other F-box proteins may also play a role in regulating Tel/Yan activity, perhaps in a tissue-specific fashion, and future studies should clarify this. The Tel/Yan SAM domain is required for association with the F-box protein Fbl6. We found that the SAM domain of both Tel (Fig. (Fig.1B)1B Tel monomers are especially labile and prone to ubiquitination. Our data support the idea that Tel/Yan monomers are more susceptible to ubiquitination and degradation than the oligomeric forms of these proteins are. Apparently, and paradoxically, the biochemical interactions between Tel/Yan monomers and Fbl6 were found to be far weaker than the interactions between Tel/Yan oligomers and Fbl6 (Fig. (Fig.3B3B Fbl6 regulates Yan protein stability. Our work suggests that Fbl6 regulates Yan protein levels in vivo. Drosophila embryos that lack fbl6 expression contain significantly elevated levels of Yan protein. Consistent with this, the levels of expression of a downstream target of Yan named argos was sharply reduced. Surprisingly, we were unable to find obvious morphological phenotypes, including during photoreceptor development (such as clear alterations in normal ommatidium development) or wing development, either in embryos, in larvae, or in adult flies that lack fbl6 expression (Alloul-Ramdhani and Baker, unpublished). Moreover, we could not observe any detectable phenotypic consequences for embryos that were deficient in fbl6 expression and also in expressing loss-of-function mutations of mae or the recently identified miR7 microRNA, both of which are also negative regulators of Yan activity in vivo (2, 21, 41, 44; Alloul-Ramdhani and Baker, unpublished). This may reflect genetic redundancy with other F-box-containing proteins or perhaps a broader role for Fbl6 as a regulator of other proteins that might counteract the function of Yan and therefore prevent any obvious mutant phenotypes resulting from elevated Yan protein levels. Indeed, in tissue culture cells, we found biochemical interactions between Fbl6 and known antagonists of Yan function, including the SAM domain-containing proteins Pointed P2 (3, 27) (but not P1, which lacks the SAM domain) and Mae (2, 33, 41) (Roukens and Baker, unpublished). Also, the nature of Tel/Yan degradation may be tissue specific and mediated by distinct or overlapping protein-degrading processes. For example, it has been suggested previously that the PEST sequences of Yan may be determinants of Yan stability (35), which may attract, or act independently of, the F-box-dependent ubiquitination system. In addition, altering the concentration of ubiquitination effectors can have a substantial impact on the function of the targeted proteins, which may influence whether or not a morphological phenotype is discernible. For example, different levels of Mdm2 have profoundly different impacts on p53 function; low levels promote p53 monoubiquitination and subsequent nuclear export, whereas high Mdm2 levels lead to polyubiquitination and proteasomal degradation (20). Normal cell development and differentiation rely upon an orchestrated program of actions that must be controlled precisely, both spatially and temporally. We describe here an evolutionarily conserved pathway of Tel/Yan downregulation. This complements our recent work on Tel sumoylation and previous studies that delineated the function of these unique repressors (2, 15, 19, 22, 27, 35, 36, 45, 46). Our future work aims to uncover further regulatory features of these crucial cellular mechanisms and to provide a unified framework for how these different processes impinge on Tel/Yan and collaboratively elicit an appropriate cellular response. [Supplemental material]
Acknowledgments We are indebted to the members of the Department of Molecular and Cellular Biology. We are grateful to Peter ten Dijke and A. G. Jochemsen for their invaluable advice during the course of the work. We are most grateful to those who very kindly provided us with materials, namely Terence Murphy and Bob Duronio for the SKPA antibody, Zhi-Chun Lai (Penn State University) for the Yan antibody, and Richard Carthew for the miR7 fly stocks. Footnotes Published ahead of print on 21 April 2008.§Supplemental material for this article may be found at http://mcb.asm.org/. REFERENCES 1. Bai, C., P. Sen, K. Hofman, L. Ma, M. Goebel, W. Harper, and S. Elledge. 1996. Skp1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86263-274. [PubMed] 2. Baker, D. A., B. Mille-Baker, S. M. Wainwright, D. Ish-Horowicz, and N. J. Dibb. 2001. Mae mediates MAP kinase phosphorylation of Ets transcription factors in Drosophila. Nature 411330-334. [PubMed] 3. Brunner, D., D. K. Ducker, N. Oellers, E. Hafen, H. Scholz, and C. Klambt. 1994. The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway. Nature 370386-389. [PubMed] 4. Cenciarelli, C., D. S. Chiaur, D. Guardavaccaro, W. Parks, M. Vidal, and M. Pagano. 1999. Identification of a family of human F-box proteins. Curr. Biol. 91177-1179. [PubMed] 5. Chakrabarti, S. R., R. Sood, S. Nandi, and G. Nucifora. 2000. Posttranslational modification of TEL and TELyAML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc. Natl. Acad. Sci. USA 9713281-13285. [PubMed] 6. Ciccarone, V. C., D. Polayes, and V. A. Luckow. 1997. Generation of recombinant baculovirus DNA in E. coli using baculovirus shuttle vector, p. 213-235, In U. Reischt (ed.), Molecular diagnosis of infectious diseases, vol. 13. Humana Press Inc., Totowa, NJ. 7. Freeman, M., C. Klambt, C. S. Goodman, and G. M. Rubin. 1992. The argos gene encodes a diffusible factor that regulates cell fate decisions in the Drosophila eye. Cell 69963-975. [PubMed] 8. Gabay, L., H. Scholz, M. Golembo, A. Klaes, B. Z. Shilo, and C. Klambt. 1996. EGF receptor signaling induces pointed P1 transcription and inactivates Yan protein in the Drosophila embryonic ventral ectoderm. Development 1223355-3362. [PubMed] 9. Golembo, M., R. Schweitzer, M. Freeman, and B.-Z. Shilo. 1996. Argos transcription is induced by the Drosophila EGF receptor pathway to form an inhibitory feedback loop. Development 122223-230. [PubMed] 10. Golub, T. R. 1997. TEL gene rearrangements in myeloid malignancy. Hematol. Oncol. Clin. North Am. 111207-1220. [PubMed] 11. Golub, T. R., G. F. Barker, K. Stegmaier, and G. D. Gilliland. 1997. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms. Curr. Top. Microbiol. Immunol. 22067-79. [PubMed] 12. Gu, X., B.-H. Shin, Y. Akbarali, A. Weiss, J. Boltax, P. Oettgen, and T. A. Libermann. 2001. Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6. J. Biol. Chem. 2769421-9436. [PubMed] 13. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67425-479. [PubMed] 14. Ho, M. S., P.-I. Tsai, and C.-T. Chien. 2006. F-box proteins: the key to protein degradation. J. Biomed. Sci. 13181-191. [PubMed] 15. Hock, H., E. Meade, S. Medeiros, J. W. Schindler, P. J. M. Valk, Y. Fujiwara, and S. H. Orkin. 2004. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev. 182336-2341. [PubMed] 16. Hoeller, D., N. Crosetto, B. Blagoev, C. Raiborg, R. Tikkanen, S. Wagner, K. Kowanetz, R. Breitling, M. Mann, H. Stenmark, and I. Dikic. 2006. Regulation of ubiquitin-binding proteins by monoubiquitination. Nat. Cell Biol. 8163-169. [PubMed] 17. Kim, C. A., M. L. Phillips, W. Kim, M. Gingery, H. H. Tran, M. A. Robinson, S. Faham, and J. U. Bowie. 2001. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J. 204173-4182. [PubMed] 18. Kipreos, E. T., and M. Pagano. 2000. The F-box protein family. Genome Biol. 1reviews3002.1-reviews3002.7. [PubMed] 19. Lai, Z. C., and G. M. Rubin. 1992. Negative control of photoreceptor development in Drosophila by the product of the yan gene, an ETS domain protein. Cell 70609-620. [PubMed] 20. Li, M., C. L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu. 2003. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 3021972-1975. [PubMed] 21. Li, X., and R. W. Carthew. 2005. A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye. Cell 1231267-1277. [PubMed] 22. Lopez, R. G., C. Carron, C. Oury, P. Gardellin, O. Bernard, and J. Ghysdael. 1999. TEL is a sequence-specific transcriptional repressor. J. Biol. Chem. 27430132-30138. [PubMed] 23. Mackereth, C. D., M. Schaarpf, L. N. Gentile, S. E. MacIntosh, C. M. Slupsky, and L. P. McIntosh. 2004. Diversity in structure and function of the Ets family PNT domains. J. Mol. Biol. 3421249-1264. [PubMed] 24. Maki, K., H. Arai, K. Waga, K. Sasaki, F. Nakamura, Y. Imai, M. Kurokawa, H. Hirai, and K. Mitani. 2004. Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Mol. Cell. Biol. 243227-3237. [PubMed] 25. Mo, Y., B. Vaessen, K. Johnston, and R. Marmorstein. 1998. Structures of SAP-1 bound to DNA targets from the E74 and c-fos promoters: insights into DNA sequence discrimination by Ets proteins. Mol. Cell 2201-212. [PubMed] 26. Murphy, T. A. 2003. Drosophila skpA, a component of SCF ubiquitin ligases, regulates centrosome duplication independently of cyclin E accumulation. J. Cell Sci. 1162321-2332. [PubMed] 27. O'Neill, E. M., I. Rebay, R. Tjian, and G. M. Rubin. 1994. The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell 78137-147. [PubMed] 28. Pickart, C. M., and M. J. Eddins. 2004. Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta 169555-72. [PubMed] 29. Poirel, H., C. Oury, C. Carron, E. Duprez, Y. Laabi, A. Tsapis, S. P. Romana, M. Mauchauffe, M. Le Coniat, R. Berger, J. Ghysdael, and O. A. Bernard. 1997. TEL gene products: nuclear phosphoproteins with DNA binding properties. Oncogene 14349-357. [PubMed] 30. Poirel, H., R. G. Lopez, V. Lacronique, V. Della Valle, M. Mauchauffé, R. Berger, J. Ghysdael, and O. A. Bernard. 2000. Characterization of a novel ETS gene, TELB, encoding a protein structurally and functionally related to TEL. Oncogene 194802-4806. [PubMed] 31. Popov, N., M. Wanzel, M. Madiredjo, D. Zhang, R. Beijersbergen, R. Bernards, R. Moll, S. J. Elledge, and M. Eilers. 2007. The ubiquitin-specific protease USP28 is required for MYC stability. Nat. Cell Biol. 9765-774. [PubMed] 32. Potter, M. D., A. Buijs, B. Kreider, L. van Rompaey, and G. C. Grosveld. 2000. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6. Blood 953341-3348. [PubMed] 33. Qiao, F., H. Song, C. A. Kim, M. R. Sawaya, J. B. Hunter, M. Gingery, I. Rebay, A. J. Courey, and J. U. Bowie. 2004. Derepression by depolymerization: structural insights into the regulation of Yan by Mae. Cell 118163-173. [PubMed] 34. Qiao, F., and J. U. Bowie. 2005. The many faces of SAM. Sci. STKE 2005re7. [PubMed] 35. Rebay, I., and G. M. Rubin. 1995. Yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway. Cell 81857-866. 36. Rogge, R., P. J. Green, J. Urano, S. Horn-Saban, M. Mlodzik, B.-Z. Shilo, V. Hartenstein, and U. Banerjee. 1995. The role of yan in mediating the choice between cell division and differentiation. Development 1213947-3958. [PubMed] 37. Roukens, M. G., M. Alloul-Ramdhani, A. C. Vertegaal, Z. Anvarian, C. I. Balog, A. M. Deelder, P. J. Hensbergen, and D. A. Baker. 2008. Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function. Mol. Cell. Biol. 282342-2357. [PubMed] 38. Sasaki, K., Y. Nakamura, K. Maki, K. Waga, F. Nakamura, H. Arai, Y. Imai, H. Hirai, and K. Mitani. 2004. Functional analysis of a dominant-negative DETS TEL/ETV6 isoform. Biochem. Biophys. Res. Commun. 3171128-1137. [PubMed] 39. Schulman, B. A., A. C. Carrano, P. D. Jeffrey, Z. Bowen, E. R. Kinnucan, M. S. Finnin, S. J. Elledge, J. W. Harper, M. Pagano, and N. P. Pavletich. 2000. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408381-386. [PubMed] 40. Song, H., M. Nie, F. Qiao, J. U. Bowie, and A. J. Courey. 2005. Antagonistic regulation of Yan nuclear export by Mae and Crm1 may increase the stringency of the Ras response. Genes Dev. 191767-1772. [PubMed] 41. Tootle, T. L., P. S. Lee, and I. Rebay. 2003. CRM1-mediated nuclear export and regulated activity of the receptor tyrosine kinase antagonist YAN require specific interactions with MAE. Development 130845-857. [PubMed] 42. Tootle, T. L., and I. Rebay. 2005. Post-translational modifications influence transcription factor activity: a view from the ETS superfamily. Bioessays 27285-298. [PubMed] 43. van Waalwijk van Doorn-Khosrovani, S. B., D. Spensberger, Y. de Knegt, M. Tang, B. Löwenberg, and R. Delwel. 2005. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Oncogene 244129-4137. [PubMed] 44. Vivekanand, P., and I. Rebay. 2006. Intersection of signal transduction pathways and development. Annu. Rev. Genet. 40139-157. [PubMed] 45. Wang, L. C., F. Kuo, Y. Fujiwara, D. G. Gilliland, T. R. Golub, and S. H. Orkin. 1997. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 164374-4383. [PubMed] 46. Wang, L. C., W. Swat, Y. Fujiwara, L. Davidson, J. Visvader, F. Kuo, F. W. Alt, D. G. Gilliland, T. R. Golub, and S. H. Orkin. 1998. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 122392-2402. [PubMed] 47. Weissman, A. M. 2001. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2169-178. [PubMed] 48. Willems, A. R., M. Schwab, and M. Tyers. 2004. A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin. Biochim. Biophys. Acta 1695133-170. [PubMed] 49. Wood, L. D., B. J. Irvin, G. Nucifora, K. S. Luce, and S. W. Hiebert. 2003. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc. Natl. Acad. Sci. USA 1003257-3562. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Genes Dev. 2004 Oct 1; 18(19):2336-41.
[Genes Dev. 2004]Cell. 1992 Aug 21; 70(4):609-20.
[Cell. 1992]J Biol Chem. 1999 Oct 15; 274(42):30132-8.
[J Biol Chem. 1999]Cell. 1994 Jul 15; 78(1):137-47.
[Cell. 1994]Development. 1995 Dec; 121(12):3947-58.
[Development. 1995]Annu Rev Biochem. 1998; 67():425-79.
[Annu Rev Biochem. 1998]Biochim Biophys Acta. 2004 Nov 29; 1695(1-3):55-72.
[Biochim Biophys Acta. 2004]Nat Cell Biol. 2006 Feb; 8(2):163-9.
[Nat Cell Biol. 2006]Science. 2003 Dec 12; 302(5652):1972-5.
[Science. 2003]Nat Rev Mol Cell Biol. 2001 Mar; 2(3):169-78.
[Nat Rev Mol Cell Biol. 2001]Nature. 2001 May 17; 411(6835):330-4.
[Nature. 2001]Mol Cell Biol. 2008 Apr; 28(7):2342-57.
[Mol Cell Biol. 2008]Cell. 1996 Jul 26; 86(2):263-74.
[Cell. 1996]Curr Biol. 1999 Oct 21; 9(20):1177-9.
[Curr Biol. 1999]Nat Cell Biol. 2007 Jul; 9(7):765-74.
[Nat Cell Biol. 2007]J Biomed Sci. 2006 Mar; 13(2):181-91.
[J Biomed Sci. 2006]Genome Biol. 2000; 1(5):REVIEWS3002.
[Genome Biol. 2000]Biochim Biophys Acta. 2004 Nov 29; 1695(1-3):133-70.
[Biochim Biophys Acta. 2004]Mol Cell Biol. 2008 Apr; 28(7):2342-57.
[Mol Cell Biol. 2008]Mol Cell. 1998 Aug; 2(2):201-12.
[Mol Cell. 1998]Oncogene. 1997 Jan 23; 14(3):349-57.
[Oncogene. 1997]Oncogene. 2005 Jun 9; 24(25):4129-37.
[Oncogene. 2005]EMBO J. 2001 Aug 1; 20(15):4173-82.
[EMBO J. 2001]Cell. 2004 Jul 23; 118(2):163-73.
[Cell. 2004]Mol Cell Biol. 2008 Apr; 28(7):2342-57.
[Mol Cell Biol. 2008]J Mol Biol. 2004 Sep 24; 342(4):1249-64.
[J Mol Biol. 2004]Sci STKE. 2005 May 31; 2005(286):re7.
[Sci STKE. 2005]J Biol Chem. 2001 Mar 23; 276(12):9421-36.
[J Biol Chem. 2001]Oncogene. 2000 Sep 28; 19(41):4802-6.
[Oncogene. 2000]Blood. 2000 Jun 1; 95(11):3341-8.
[Blood. 2000]Nature. 2001 May 17; 411(6835):330-4.
[Nature. 2001]Cell. 2004 Jul 23; 118(2):163-73.
[Cell. 2004]Genes Dev. 2005 Aug 1; 19(15):1767-72.
[Genes Dev. 2005]Development. 2003 Mar; 130(5):845-57.
[Development. 2003]Cell. 1996 Jul 26; 86(2):263-74.
[Cell. 1996]Cell. 1992 Jun 12; 69(6):963-75.
[Cell. 1992]Development. 1996 Nov; 122(11):3355-62.
[Development. 1996]Development. 1996 Jan; 122(1):223-30.
[Development. 1996]Genes Dev. 2004 Oct 1; 18(19):2336-41.
[Genes Dev. 2004]Cell. 1992 Aug 21; 70(4):609-20.
[Cell. 1992]J Biol Chem. 1999 Oct 15; 274(42):30132-8.
[J Biol Chem. 1999]Cell. 1994 Jul 15; 78(1):137-47.
[Cell. 1994]Development. 1995 Dec; 121(12):3947-58.
[Development. 1995]J Mol Biol. 2004 Sep 24; 342(4):1249-64.
[J Mol Biol. 2004]Cell. 2004 Jul 23; 118(2):163-73.
[Cell. 2004]Nature. 1994 Aug 4; 370(6488):386-9.
[Nature. 1994]Cell. 1994 Jul 15; 78(1):137-47.
[Cell. 1994]Nature. 2001 May 17; 411(6835):330-4.
[Nature. 2001]Mol Cell Biol. 2004 Apr; 24(8):3227-37.
[Mol Cell Biol. 2004]Mol Cell Biol. 2008 Apr; 28(7):2342-57.
[Mol Cell Biol. 2008]Sci STKE. 2005 May 31; 2005(286):re7.
[Sci STKE. 2005]Bioessays. 2005 Mar; 27(3):285-98.
[Bioessays. 2005]Annu Rev Genet. 2006; 40():139-57.
[Annu Rev Genet. 2006]Nature. 2001 May 17; 411(6835):330-4.
[Nature. 2001]Cell. 2005 Dec 29; 123(7):1267-77.
[Cell. 2005]Development. 2003 Mar; 130(5):845-57.
[Development. 2003]Annu Rev Genet. 2006; 40():139-57.
[Annu Rev Genet. 2006]Nature. 1994 Aug 4; 370(6488):386-9.
[Nature. 1994]Nature. 2001 May 17; 411(6835):330-4.
[Nature. 2001]Genes Dev. 2004 Oct 1; 18(19):2336-41.
[Genes Dev. 2004]Cell. 1992 Aug 21; 70(4):609-20.
[Cell. 1992]J Biol Chem. 1999 Oct 15; 274(42):30132-8.
[J Biol Chem. 1999]Cell. 1994 Jul 15; 78(1):137-47.
[Cell. 1994]Cell. 1996 Jul 26; 86(2):263-74.
[Cell. 1996]Curr Biol. 1999 Oct 21; 9(20):1177-9.
[Curr Biol. 1999]Mol Cell Biol. 2008 Apr; 28(7):2342-57.
[Mol Cell Biol. 2008]